GGrantIndex
Sort

39,280 grants matching leukemia

Dissecting and engineering CAR T-cell function for optimized Immunotherapy

$342,716
Weiqiang Chen · New York University · R35 · FY2021 · GM

Regulation and Targets of the DNA Damage Checkpoint

$342,666
David P Toczyski · University Of California, San Francisco · R01 · FY2008 · GM

Pathways of Immune Evasion in Acute Myeloid Leukemia

$342,648
Evan Ferguson Lind · Oregon Health & Science University · R01 · FY2023 · CA

Targeting EGR1 signaling pathways in diffuse large B cell lymphoma

$342,620
Lixin Rui · University Of Wisconsin-Madison · R01 · FY2023 · CA

Development of therapeutic chemokine-based formulations

$342,595
Arya Biragyn · National Institute On Aging · ZIA · FY2013 · AG

The role and functional mechanism of TET1 in MLL-rearranged leukemia

$342,579
Jianjun Chen · University Of Cincinnati · R01 · FY2015 · CA

Biology and Targeting of noncoding RNAs in AML

$342,534
Ramiro Garzon · University Of Utah · R01 · FY2023 · CA

Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities

$342,530
Caroline Avery Thompson · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

Shared Resource 08: Genomics (GSR)

$342,523
Amanda Ewart Toland · Ohio State University · P30 · FY2021 · CA

IN UTERO TRANSFER OF HEMATOPOIETIC CELLS

$342,505
University Of Minnesota Twin Cities · R01 · FY2002 · HL

Factor-general characterization of dynamic transcriptional stress responses

$342,489
Adam Charles Siepel · Cornell University · R01 · FY2013 · HG

Genomics Shared Resource

$342,476
David Eric Symer · Ohio State University · P30 · FY2020 · CA

Project 4 - Targeting AML using novel bispecific and antibody-drug conjugates.

$342,469
John F Dipersio · Washington University · P50 · FY2018 · CA

Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.

$342,469
Todd A Fehniger · Washington University · P50 · FY2018 · CA

Project 2 - Targeted Therapies for T-ALL.

$342,469
Geoffrey L Uy · Washington University · P50 · FY2018 · CA

TEL, AML1, and TEL/AML1 in Hematopoiesis

$342,467
Giuseppina Nucifora · University Of Illinois At Chicago · R01 · FY2006 · HL

Core - Clinical Res. Operations - Leadership

$342,417
Edward J Benz · Dana-Farber Cancer Inst · P30 · FY2008 · CA

Targeting Endoplasmic Reticulum Stress Sensor IRE1 to Enhance Chemotherapy Sensitivity in MYC-driven breast cancer

$342,417
Xi Chen · Baylor College Of Medicine · P50 · FY2021 · CA

CSF2 receptor mediated actions in t(8;21) leukemia

$342,403
Dong-Er Zhang · University Of California, San Diego · R01 · FY2018 · CA

Project 1: Microbiology of ME/CFS

$342,394
W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2017 · AI

KillerRed Assisted Mutagenesis to discover cancer drug resistance genes

$342,375
Daniel G. Jay · Tufts University Boston · R01 · FY2012 · CA

Polysomy 21 in Acute Lymphoblastic Leukemia

$342,358
David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2014 · CA

Regulation of non-histone protein functions by histone deacetylases

$342,350
Edward Seto · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · GM

Regulation of non-histone protein functions by histone deacetylases

$342,350
Edward Seto · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · GM

Architectural Basis of Leptin Transmembrane Signaling

$342,327
Georgios Skiniotis · University Of Michigan At Ann Arbor · R01 · FY2012 · DK